spacer

CDC HomeHIV/AIDS > Topics > Statistics and Surveillance > Guidelines > Integrated Guidelines for Developing Epidemiologic Profiles > Sample

Sample: Integrated Epidemiologic Profile for HIV/AIDS Prevention and Care Planning–Louisiana, 2002
space
arrow Acknowledgements
space
arrow List of Figures
space
arrow List of Tables
space
arrow Executive Summary
space
arrow Introduction
space
arrow Section 1
space
arrow Section 2
space
arrow Appendixes
space
arrow Glossary
space
arrow Abbreviations
space
 
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
Skip Nav spacer
Section 1: Core Epidemiologic Questions
spacer
spacer

HIV/AIDS, by Race/Ethnicity and Sex

The epidemic significantly affects both males and females in the black and Hispanic communities (Table 9). In 2001, the rate of HIV diagnosis for black males was almost 1.5 times the rate for Hispanic males and nearly 5 times the rate for white males. The rate of HIV diagnoses for black women was more than 11 times that for white women. Rates were not calculated for other ethnic groups because of the small number of cases.

Overall, the number of new HIV cases diagnosed has been declining among white and black men; however, this same decrease in rates has not been seen among black or white women (Figure 4). The annual number of new HIV cases among black women has been higher than that among white men since 1993.

Figure 4: Trends in HIV/AIDS, by Ethnicity and Sex
Louisiana, 1997-2001

Graphic for Figure 4.

HIV counseling and testing data provide information on new HIV diagnoses among persons who are tested at public sites, such as STD, family planning, prenatal, and TB clinics; drug treatment centers; CBOs; parish health units; community health centers; and mobile test sites. Among persons tested for the first time, the percentage of seropositive results was higher among males than females (Figure 5). In 2001, compared with 2000, the percentage of seropositive results among females increased significantly. The percentage of seropositive results among males decreased in 1998 and 1999 and then increased slightly in 2000 and 2001. HIV seropositivity is highest among blacks, and the percentage increased substantially in this population in 2001 (Figure 6).

Figure 5: Percentage of Positivity Among Persons Tested for the First Time, by Sex
Louisiana Counseling and Testing Data, 1997-2001

Graphic for Figure 5.

Figure 6: Percentage of Positivity Among Persons Tested for the First Time, by Race
Louisiana Counseling and Testing Data, 1997-2001

Graphic for Figure 6.

HIV/AIDS, by Age Group

In 2001, persons aged 25–44 years accounted for more than half (56%) of the newly diagnosed cases. Females accounted for a higher proportion of cases among youth (13–24 years) than in any other adult age groups (Table 10). This may be due in part to more opportunities for HIV screening of young women, such as during routine HIV screening of pregnant women.

In 2001, as in past years, the highest number of newly diagnosed cases was among persons 25–44 years of age (Figure 7). However, the diagnosis of HIV for persons in this age group has been declining substantially since 1997. The decrease in this age group accounts for much of the decline in the number of new HIV cases seen in recent years.

HIV seropositivity is highest in the age group 35–39 years and lowest in the age group 13–19 years (Figure 8). In 2001, HIV seropositivity increased in almost all age groups, but the most dramatic increase was in the age group 35–39 years.

Figure 7: Trends in HIV/AIDS, by Age Group
Louisiana, 1997-2001

Graphic for Figure 7.

Figure 8: Percentage of Positivity Among Persons Tested for the First Time, by Age Group
Louisiana Counseling and Testing Data, 1997-2001

Graphic for Figure 8.

Go to HIV/AIDS, by Mode of Exposure

Last Modified: July 18, 2007
Last Reviewed: July 18, 2007
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services